Clearline Capital LP Q2 2023 Filing
Filed August 15, 2023
Portfolio Value
$1.7B
Holdings
114
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (114 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 101 | LNSRLENSAR INC | 116,013 | $493.1B | 28578.53% | |
| 102 | LYRALYRA THERAPEUTICS INC | 119,128 | $489.6B | 28379.14% | |
| 103 | SPRYARS PHARMACEUTICALS INC | 61,102 | $409.4B | 23728.73% | |
| 104 | CGNTCOGNYTE SOFTWARE LTD | 63,873 | $389.0B | 22546.48% | |
| 105 | QSIQUANTUM SI INC | 211,900 | $379.3B | 21985.06% | |
| 106 | INUVGBPINUVO INC | 1,542,607 | $342.5B | 19849.62% | |
| 107 | CTMXCYTOMX THERAPEUTICS INC | 196,583 | $338.1B | 19598.24% | |
| 108 | ORGNWORIGIN MATERIALS INC | 395,297 | $292.5B | 16952.74% | |
| 109 | —NERDY INC | 510,400 | $279.7B | 16211.93% | |
| 110 | PAYOPAYONEER GLOBAL INC | 53,522 | $257.4B | 14921.75% | |
| 111 | EX9EXELIXIS INC | 12,939 | $247.3B | 14331.93% | |
| 112 | —VINCERX PHARMA INC | 98,916 | $128.6B | 7453.40% | |
| 113 | GDEVGDEV INC | 338,196 | $40.6B | 2352.33% | |
| 114 | NUVB/WSNUVATION BIO INC | 33,271 | $5.5B | 318.97% |
PreviousPage 2 of 2